Illuminare Biotechnologies Inc, 2026-06-04
An SEC Form D private-offering notice from Brooklyn, NY, a $4,000,000 filer-stated offering target in Biotech. Filed 2026-06-04. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical stage biotech developing a small molecule to improve real time intraoperative nerve visualization for surgeons, reducing unintended nerve injury.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Spine BioPharma, Inc., 2026-06-05, $8.5M, New York, NY
- Bluera Inc., 2026-06-04, $200K, New York, NY
- Antlia Bioscience, Inc., 2026-06-05, $20M, Encinitas, CA
- RSA HoldCo LLC, 2026-06-04, $2M, New York, NY
- Crossject SA, 2026-06-05, $10.3M, Dijon
- albane meaningful giving, Inc., 2026-06-03, $950K, New York, NY
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.